{
  "validation_metadata": {
    "timestamp": "20250908_192501",
    "test_model": "deepseek-coder",
    "prompts_tested": [
      "direct_mcode_simple",
      "direct_mcode_evidence_based_concise"
    ],
    "trials_count": 2,
    "validation_version": "1.0"
  },
  "results": {
    "direct_mcode_simple": {
      "prompt_name": "direct_mcode_simple",
      "model_name": "deepseek-coder",
      "trials_processed": 2,
      "total_processing_time": 615.1856620311737,
      "trial_results": [
        {
          "trial_id": "NCT01922921",
          "processing_time": 404.76393008232117,
          "mcode_mappings": [
            {
              "resourceType": "Observation",
              "mcode_element": "ResearchStudy",
              "code": {
                "system": "http://hl7.org/fhir/us/mCODE",
                "code": "researchstudy",
                "display": "ResearchStudy"
              },
              "value": "interventional",
              "mapping_confidence": 0.0,
              "source_text_fragment": "Entity index unknown",
              "mapping_rationale": "TREATMENT purpose indicates an interventional study type per FHIR ResearchStudy",
              "id": "64d3927e-4d3a-4a9d-a2c7-4391e71f0ca2"
            },
            {
              "resourceType": "Observation",
              "mcode_element": "ResearchStudy",
              "code": {
                "system": "http://hl7.org/fhir/us/mCODE",
                "code": "researchstudy",
                "display": "ResearchStudy"
              },
              "value": "RANDOMIZED",
              "mapping_confidence": 0.0,
              "source_text_fragment": "Entity index unknown",
              "mapping_rationale": "RANDOMIZED allocation directly maps to FHIR ResearchStudy design",
              "id": "50e40a19-6361-4f92-8aa6-bb6e0a150a6f"
            },
            {
              "resourceType": "Observation",
              "mcode_element": "ResearchStudy",
              "code": {
                "system": "http://hl7.org/fhir/us/mCODE",
                "code": "researchstudy",
                "display": "ResearchStudy"
              },
              "value": "PARALLEL",
              "mapping_confidence": 0.0,
              "source_text_fragment": "Entity index unknown",
              "mapping_rationale": "PARALLEL intervention model directly maps to FHIR ResearchStudy design",
              "id": "8e13c7f9-5189-46cc-acca-2a3321018745"
            },
            {
              "resourceType": "Observation",
              "mcode_element": "ResearchStudy",
              "code": {
                "system": "http://hl7.org/fhir/us/mCODE",
                "code": "researchstudy",
                "display": "ResearchStudy"
              },
              "value": "DOUBLE",
              "mapping_confidence": 0.0,
              "source_text_fragment": "Entity index unknown",
              "mapping_rationale": "DOUBLE masking directly maps to FHIR ResearchStudy masking type",
              "id": "221d02ca-5ea2-4e21-864a-3a490b3f86c7"
            },
            {
              "resourceType": "Observation",
              "mcode_element": "ResearchStudy",
              "code": {
                "system": "http://hl7.org/fhir/us/mCODE",
                "code": "researchstudy",
                "display": "ResearchStudy"
              },
              "value": "PARTICIPANT",
              "mapping_confidence": 0.0,
              "source_text_fragment": "Entity index unknown",
              "mapping_rationale": "PARTICIPANT role directly maps to FHIR ResearchStudy masked roles",
              "id": "23d97b5f-e8e4-41c5-9308-7b074eb7b0a2"
            },
            {
              "resourceType": "Observation",
              "mcode_element": "ResearchStudy",
              "code": {
                "system": "http://hl7.org/fhir/us/mCODE",
                "code": "researchstudy",
                "display": "ResearchStudy"
              },
              "value": "INVESTIGATOR",
              "mapping_confidence": 0.0,
              "source_text_fragment": "Entity index unknown",
              "mapping_rationale": "INVESTIGATOR role directly maps to FHIR ResearchStudy masked roles",
              "id": "0e5b22d6-b65d-4b44-baa6-bf9e7f6614d3"
            },
            {
              "resourceType": "Condition",
              "mcode_element": "CancerCondition",
              "code": {
                "system": "http://hl7.org/fhir/us/mCODE",
                "code": "cancercondition",
                "display": "CancerCondition"
              },
              "value": "active",
              "mapping_confidence": 0.0,
              "source_text_fragment": "Entity index unknown",
              "mapping_rationale": "Mapped to SNOMED CT code for malignant breast neoplasm, with 'recurrent' indicating active disease status",
              "id": "f3dddc9e-858f-4a17-b552-5a2a90c451d7"
            },
            {
              "resourceType": "Condition",
              "mcode_element": "CancerCondition",
              "code": {
                "system": "http://hl7.org/fhir/us/mCODE",
                "code": "cancercondition",
                "display": "CancerCondition"
              },
              "value": "active",
              "mapping_confidence": 0.0,
              "source_text_fragment": "Entity index unknown",
              "mapping_rationale": "Mapped to SNOMED CT code for malignant breast neoplasm, with stage IV indicating advanced active disease",
              "id": "00134033-9194-4bbb-978b-09a52239f813"
            },
            {
              "resourceType": "Observation",
              "mcode_element": "CancerDiseaseStatus",
              "code": {
                "system": "http://hl7.org/fhir/us/mCODE",
                "code": "cancerdiseasestatus",
                "display": "CancerDiseaseStatus"
              },
              "value": "recurrence",
              "mapping_confidence": 0.0,
              "source_text_fragment": "Entity index unknown",
              "mapping_rationale": "'Recurrent' indicates disease recurrence status per mCODE value set",
              "id": "9653d0d5-b234-4b1f-92ce-a791140c7fba"
            },
            {
              "resourceType": "Observation",
              "mcode_element": "TNMStageGroup",
              "code": {
                "system": "http://hl7.org/fhir/us/mCODE",
                "code": "tnmstagegroup",
                "display": "TNMStageGroup"
              },
              "value": "IV",
              "mapping_confidence": 0.0,
              "source_text_fragment": "Entity index unknown",
              "mapping_rationale": "Direct mapping of 'Stage IV' to TNM stage group using cancer staging terminology",
              "id": "d6b95ef0-0cd0-4f9e-9f74-21a96574ca97"
            },
            {
              "resourceType": "Observation",
              "mcode_element": "GenomicVariant",
              "code": {
                "system": "http://hl7.org/fhir/us/mCODE",
                "code": "genomicvariant",
                "display": "GenomicVariant"
              },
              "value": "positive",
              "mapping_confidence": 0.0,
              "source_text_fragment": "Entity index unknown",
              "mapping_rationale": "HER2/Neu maps to ERBB2 gene (HGNC:3430), 'Positive' indicates variant presence",
              "id": "6ff702b8-be1a-47ea-8d1c-b88f63c79dc8"
            },
            {
              "resourceType": "Condition",
              "mcode_element": "CancerCondition",
              "code": {
                "system": "http://hl7.org/fhir/us/mCODE",
                "code": "cancercondition",
                "display": "CancerCondition"
              },
              "value": "stage IV HER2+ breast cancer",
              "mapping_confidence": 0.0,
              "source_text_fragment": "Entity index unknown",
              "mapping_rationale": "Direct mapping to cancer condition with stage and HER2 status specified",
              "id": "f882cc4d-dd69-4a32-9bbd-0808f5dfe09a"
            },
            {
              "resourceType": "Observation",
              "mcode_element": "CancerDiseaseStatus",
              "code": {
                "system": "http://hl7.org/fhir/us/mCODE",
                "code": "cancerdiseasestatus",
                "display": "CancerDiseaseStatus"
              },
              "value": "No evidence of disease (NED)",
              "mapping_confidence": 0.0,
              "source_text_fragment": "Entity index unknown",
              "mapping_rationale": "Clear disease status observation from inclusion criteria",
              "id": "3fb5f032-daa9-4fc8-a75a-42313991660a"
            },
            {
              "resourceType": "Observation",
              "mcode_element": "CancerDiseaseStatus",
              "code": {
                "system": "http://hl7.org/fhir/us/mCODE",
                "code": "cancerdiseasestatus",
                "display": "CancerDiseaseStatus"
              },
              "value": "Stable bone only disease",
              "mapping_confidence": 0.0,
              "source_text_fragment": "Entity index unknown",
              "mapping_rationale": "Clear disease status observation with metastatic site specified",
              "id": "e52f2a2d-aee9-4dca-9605-8c4de8db6838"
            },
            {
              "resourceType": "Observation",
              "mcode_element": "GenomicVariant",
              "code": {
                "system": "http://hl7.org/fhir/us/mCODE",
                "code": "genomicvariant",
                "display": "GenomicVariant"
              },
              "value": "HER2 overexpression by immunohistochemistry (IHC) of 2+ or 3+",
              "mapping_confidence": 0.0,
              "source_text_fragment": "Entity index unknown",
              "mapping_rationale": "HER2 genomic variant testing results with specific IHC scores",
              "id": "da2c44f4-dde8-40be-a6d7-dabb45e5056f"
            },
            {
              "resourceType": "Observation",
              "mcode_element": "GenomicVariant",
              "code": {
                "system": "http://hl7.org/fhir/us/mCODE",
                "code": "genomicvariant",
                "display": "GenomicVariant"
              },
              "value": "HER2 gene amplification documented by FISH analysis",
              "mapping_confidence": 0.0,
              "source_text_fragment": "Entity index unknown",
              "mapping_rationale": "HER2 genomic variant testing using FISH methodology",
              "id": "0a689150-6d35-47d9-81b1-97d9b4c91ba1"
            },
            {
              "resourceType": "Observation",
              "mcode_element": "CancerRelatedMedicationAdministration",
              "code": {
                "system": "http://hl7.org/fhir/us/mCODE",
                "code": "cancerrelatedmedicationadministration",
                "display": "CancerRelatedMedicationAdministration"
              },
              "value": "trastuzumab monotherapy",
              "mapping_confidence": 0.0,
              "source_text_fragment": "Entity index unknown",
              "mapping_rationale": "HER2-targeted monoclonal antibody therapy specified in treatment criteria",
              "id": "90cbaca7-efec-48b6-bc77-210ecb7f4b1b"
            },
            {
              "resourceType": "Observation",
              "mcode_element": "CancerRelatedMedicationAdministration",
              "code": {
                "system": "http://hl7.org/fhir/us/mCODE",
                "code": "cancerrelatedmedicationadministration",
                "display": "CancerRelatedMedicationAdministration"
              },
              "value": "trastuzumab and pertuzumab combination therapy",
              "mapping_confidence": 0.0,
              "source_text_fragment": "Entity index unknown",
              "mapping_rationale": "HER2-targeted combination therapy specified in treatment criteria",
              "id": "4e5599a8-12f5-49ee-83e7-7ef05d9a9eed"
            },
            {
              "resourceType": "Observation",
              "mcode_element": "ECOGPerformanceStatus",
              "code": {
                "system": "http://hl7.org/fhir/us/mCODE",
                "code": "ecogperformancestatus",
                "display": "ECOGPerformanceStatus"
              },
              "value": "Zubrod performance status score of =< 2",
              "mapping_confidence": 0.0,
              "source_text_fragment": "Entity index unknown",
              "mapping_rationale": "Performance status assessment using Zubrod/ECOG scale with score threshold",
              "id": "e0f9bcd1-dd89-4f57-8431-ed0ea807aded"
            },
            {
              "resourceType": "Observation",
              "mcode_element": "LaboratoryResult",
              "code": {
                "system": "http://hl7.org/fhir/us/mCODE",
                "code": "laboratoryresult",
                "display": "LaboratoryResult"
              },
              "value": "White blood cell (WBC) >= 3000/mm^3",
              "mapping_confidence": 0.0,
              "source_text_fragment": "Entity index unknown",
              "mapping_rationale": "Laboratory result threshold for white blood cell count",
              "id": "26fd4e83-afa4-401a-a22e-ca721340406c"
            },
            {
              "resourceType": "Observation",
              "mcode_element": "LaboratoryResult",
              "code": {
                "system": "http://hl7.org/fhir/us/mCODE",
                "code": "laboratoryresult",
                "display": "LaboratoryResult"
              },
              "value": "Hemoglobin (Hgb) >= 10 g/dl",
              "mapping_confidence": 0.0,
              "source_text_fragment": "Entity index unknown",
              "mapping_rationale": "Laboratory result threshold for hemoglobin level",
              "id": "e40c234f-438f-486b-a94e-0ff8fc81397c"
            },
            {
              "resourceType": "Observation",
              "mcode_element": "LaboratoryResult",
              "code": {
                "system": "http://hl7.org/fhir/us/mCODE",
                "code": "laboratoryresult",
                "display": "LaboratoryResult"
              },
              "value": "Serum creatinine =< 2.0 mg/dl",
              "mapping_confidence": 0.0,
              "source_text_fragment": "Entity index unknown",
              "mapping_rationale": "Laboratory result threshold for serum creatinine",
              "id": "b38be338-6241-4d89-90b1-b20ab857bef5"
            },
            {
              "resourceType": "Observation",
              "mcode_element": "LaboratoryResult",
              "code": {
                "system": "http://hl7.org/fhir/us/mCODE",
                "code": "laboratoryresult",
                "display": "LaboratoryResult"
              },
              "value": "Total bilirubin =< 1.5 mg/dl",
              "mapping_confidence": 0.0,
              "source_text_fragment": "Entity index unknown",
              "mapping_rationale": "Laboratory result threshold for total bilirubin",
              "id": "02fec6af-3ea4-43a4-8e9c-fc7f65ebcdc5"
            },
            {
              "resourceType": "Observation",
              "mcode_element": "LaboratoryResult",
              "code": {
                "system": "http://hl7.org/fhir/us/mCODE",
                "code": "laboratoryresult",
                "display": "LaboratoryResult"
              },
              "value": "SGOT =< 2.5 times the upper limit of normal",
              "mapping_confidence": 0.0,
              "source_text_fragment": "Entity index unknown",
              "mapping_rationale": "Laboratory result threshold for SGOT/AST liver enzyme",
              "id": "2d3635e3-df99-4822-b0fa-9aff556b9dfa"
            },
            {
              "resourceType": "Observation",
              "mcode_element": "CardiacFunction",
              "code": {
                "system": "http://hl7.org/fhir/us/mCODE",
                "code": "cardiacfunction",
                "display": "CardiacFunction"
              },
              "value": "normal left ventricular ejection fraction (LVEF) >= the lower limit of normal",
              "mapping_confidence": 0.0,
              "source_text_fragment": "Entity index unknown",
              "mapping_rationale": "Cardiac function assessment with LVEF measurement and normal range specification",
              "id": "8fb8df64-3504-466f-8541-b1df144d6450"
            },
            {
              "resourceType": "Observation",
              "mcode_element": "Comorbidity",
              "code": {
                "system": "http://hl7.org/fhir/us/mCODE",
                "code": "comorbidity",
                "display": "Comorbidity"
              },
              "value": "Restrictive cardiomyopathy",
              "mapping_confidence": 0.0,
              "source_text_fragment": "Entity index unknown",
              "mapping_rationale": "Cardiac comorbidity listed in exclusion criteria",
              "id": "761c6c84-5778-4eef-bc36-d9070e57f56b"
            },
            {
              "resourceType": "Observation",
              "mcode_element": "Comorbidity",
              "code": {
                "system": "http://hl7.org/fhir/us/mCODE",
                "code": "comorbidity",
                "display": "Comorbidity"
              },
              "value": "Unstable angina within 6 months prior to enrollment",
              "mapping_confidence": 0.0,
              "source_text_fragment": "Entity index unknown",
              "mapping_rationale": "Cardiac comorbidity with temporal constraint in exclusion criteria",
              "id": "55f2881d-299b-461e-a8aa-94bdf6911bd6"
            },
            {
              "resourceType": "Observation",
              "mcode_element": "Comorbidity",
              "code": {
                "system": "http://hl7.org/fhir/us/mCODE",
                "code": "comorbidity",
                "display": "Comorbidity"
              },
              "value": "New York Heart Association functional class III-IV heart failure",
              "mapping_confidence": 0.0,
              "source_text_fragment": "Entity index unknown",
              "mapping_rationale": "Cardiac comorbidity with severity classification in exclusion criteria",
              "id": "d652169c-04b6-4276-98ff-76422b9b23e1"
            },
            {
              "resourceType": "Observation",
              "mcode_element": "Comorbidity",
              "code": {
                "system": "http://hl7.org/fhir/us/mCODE",
                "code": "comorbidity",
                "display": "Comorbidity"
              },
              "value": "Symptomatic pericardial effusion",
              "mapping_confidence": 0.0,
              "source_text_fragment": "Entity index unknown",
              "mapping_rationale": "Cardiac comorbidity with symptom specification in exclusion criteria",
              "id": "9359624f-7a39-4c62-89e5-5d9080c2e2b8"
            },
            {
              "resourceType": "Observation",
              "mcode_element": "Patient",
              "code": {
                "system": "http://hl7.org/fhir/us/mCODE",
                "code": "patient",
                "display": "Patient"
              },
              "value": "minimumAge: 18 Years",
              "mapping_confidence": 0.0,
              "source_text_fragment": "Entity index unknown",
              "mapping_rationale": "Minimum age requirement for patient eligibility",
              "id": "a2c29176-6ef1-4d34-a596-e127c623f17a"
            },
            {
              "resourceType": "Condition",
              "mcode_element": "CancerCondition",
              "code": {
                "system": "http://hl7.org/fhir/us/mCODE",
                "code": "cancercondition",
                "display": "CancerCondition"
              },
              "value": "stage IV human epidermal growth factor receptor 2 (HER2) positive breast cancer",
              "mapping_confidence": 0.0,
              "source_text_fragment": "Entity index unknown",
              "mapping_rationale": "Text clearly describes cancer condition with stage and HER2 status",
              "id": "99a6a751-c402-41ba-86c9-dc367f7bbb92"
            },
            {
              "resourceType": "Observation",
              "mcode_element": "CancerDiseaseStatus",
              "code": {
                "system": "http://hl7.org/fhir/us/mCODE",
                "code": "cancerdiseasestatus",
                "display": "CancerDiseaseStatus"
              },
              "value": "unknown",
              "mapping_confidence": 0.0,
              "source_text_fragment": "Entity index unknown",
              "mapping_rationale": "Text indicates disease status/outcome is unknown for the treatment comparison",
              "id": "c2ab4baf-1fad-4a00-b436-3935b3bcedd7"
            },
            {
              "resourceType": "Observation",
              "mcode_element": "CancerRelatedMedicationStatement",
              "code": {
                "system": "http://hl7.org/fhir/us/mCODE",
                "code": "cancerrelatedmedicationstatement",
                "display": "CancerRelatedMedicationStatement"
              },
              "value": "trastuzumab",
              "mapping_confidence": 0.0,
              "source_text_fragment": "Entity index unknown",
              "mapping_rationale": "Trastuzumab is explicitly mentioned as HER2-targeted therapy",
              "id": "48cc3e9c-f54b-47a4-8c20-154b0a14d507"
            },
            {
              "resourceType": "Observation",
              "mcode_element": "CancerRelatedMedicationStatement",
              "code": {
                "system": "http://hl7.org/fhir/us/mCODE",
                "code": "cancerrelatedmedicationstatement",
                "display": "CancerRelatedMedicationStatement"
              },
              "value": "pertuzumab",
              "mapping_confidence": 0.0,
              "source_text_fragment": "Entity index unknown",
              "mapping_rationale": "Pertuzumab is mentioned as alternative or combination therapy",
              "id": "2bbcde5a-60c6-48b4-9048-30537e9d2a8c"
            },
            {
              "resourceType": "Observation",
              "mcode_element": "CancerRelatedMedicationStatement",
              "code": {
                "system": "http://hl7.org/fhir/us/mCODE",
                "code": "cancerrelatedmedicationstatement",
                "display": "CancerRelatedMedicationStatement"
              },
              "value": "polysaccharide-K",
              "mapping_confidence": 0.0,
              "source_text_fragment": "Entity index unknown",
              "mapping_rationale": "Polysaccharide-K is an investigational medication in the trial",
              "id": "da1de773-6f44-426a-b9d6-c1914fa9638f"
            },
            {
              "resourceType": "Observation",
              "mcode_element": "CancerRelatedSurgicalProcedure",
              "code": {
                "system": "http://hl7.org/fhir/us/mCODE",
                "code": "cancerrelatedsurgicalprocedure",
                "display": "CancerRelatedSurgicalProcedure"
              },
              "value": "vaccine therapy",
              "mapping_confidence": 0.0,
              "source_text_fragment": "Entity index unknown",
              "mapping_rationale": "Vaccine therapy is a form of cancer immunotherapy procedure",
              "id": "85b125db-0150-4d70-aa89-e8e4521e7f50"
            },
            {
              "resourceType": "Observation",
              "mcode_element": "TumorMarker",
              "code": {
                "system": "http://hl7.org/fhir/us/mCODE",
                "code": "tumormarker",
                "display": "TumorMarker"
              },
              "value": "positive",
              "mapping_confidence": 0.0,
              "source_text_fragment": "Entity index unknown",
              "mapping_rationale": "HER2 positive status is a key tumor marker for patient selection",
              "id": "2febc452-7c44-4f63-bac1-5d3d5827b6b3"
            },
            {
              "resourceType": "Observation",
              "mcode_element": "TumorMarker",
              "code": {
                "system": "http://hl7.org/fhir/us/mCODE",
                "code": "tumormarker",
                "display": "TumorMarker"
              },
              "value": "natural killer (NK) cell functional activity",
              "mapping_confidence": 0.0,
              "source_text_fragment": "Entity index unknown",
              "mapping_rationale": "NK cell activity is measured as a secondary objective biomarker",
              "id": "e2c937d2-06a4-4f6f-ba80-bbbe9182a33c"
            },
            {
              "resourceType": "Observation",
              "mcode_element": "TumorMarker",
              "code": {
                "system": "http://hl7.org/fhir/us/mCODE",
                "code": "tumormarker",
                "display": "TumorMarker"
              },
              "value": "serum transforming growth factor (TGF)-beta levels",
              "mapping_confidence": 0.0,
              "source_text_fragment": "Entity index unknown",
              "mapping_rationale": "TGF-beta is measured as a tertiary objective biomarker",
              "id": "b41df7e4-3e6b-48b4-a91f-9f2818555b1c"
            },
            {
              "resourceType": "Observation",
              "mcode_element": "CancerDiseaseStatus",
              "code": {
                "system": "http://hl7.org/fhir/us/mCODE",
                "code": "cancerdiseasestatus",
                "display": "CancerDiseaseStatus"
              },
              "value": "progression free survival (PFS)",
              "mapping_confidence": 0.0,
              "source_text_fragment": "Entity index unknown",
              "mapping_rationale": "PFS is explicitly mentioned as a tertiary outcome measure",
              "id": "84abedf8-d9b1-4de5-9cb6-1da5fac18dd5"
            },
            {
              "resourceType": "Observation",
              "mcode_element": "CancerDiseaseStatus",
              "code": {
                "system": "http://hl7.org/fhir/us/mCODE",
                "code": "cancerdiseasestatus",
                "display": "CancerDiseaseStatus"
              },
              "value": "overall survival (OS)",
              "mapping_confidence": 0.0,
              "source_text_fragment": "Entity index unknown",
              "mapping_rationale": "OS is explicitly mentioned as a tertiary outcome measure",
              "id": "0ee8be85-34ee-4c94-849c-553a70d60f6c"
            },
            {
              "resourceType": "Observation",
              "mcode_element": "RadiationProcedure",
              "code": {
                "system": "http://hl7.org/fhir/us/mCODE",
                "code": "radiationprocedure",
                "display": "RadiationProcedure"
              },
              "value": "phase I/II trial",
              "mapping_confidence": 0.0,
              "source_text_fragment": "Entity index unknown",
              "mapping_rationale": "Clinical trial phase indicates radiation/oncology procedure context",
              "id": "42e6c0e3-3b0f-4dc5-ac55-2ecc2f3204c8"
            },
            {
              "resourceType": "Condition",
              "mcode_element": "CancerCondition",
              "code": {
                "system": "http://hl7.org/fhir/us/mCODE",
                "code": "cancercondition",
                "display": "CancerCondition"
              },
              "value": "present",
              "mapping_confidence": 0.0,
              "source_text_fragment": "Entity index unknown",
              "mapping_rationale": "Text explicitly states breast cancer diagnosis with stage IV and HER2 positive status",
              "id": "0793fdc1-949a-4cf4-9469-3c842f5f0ae9"
            },
            {
              "resourceType": "Observation",
              "mcode_element": "CancerDiseaseStatus",
              "code": {
                "system": "http://hl7.org/fhir/us/mCODE",
                "code": "cancerdiseasestatus",
                "display": "CancerDiseaseStatus"
              },
              "value": "IV",
              "mapping_confidence": 0.0,
              "source_text_fragment": "Entity index unknown",
              "mapping_rationale": "Clear staging information provided as Stage IV breast cancer",
              "id": "f34a10eb-ede8-4009-9926-291056e3c4f7"
            },
            {
              "resourceType": "Observation",
              "mcode_element": "GenomicVariant",
              "code": {
                "system": "http://hl7.org/fhir/us/mCODE",
                "code": "genomicvariant",
                "display": "GenomicVariant"
              },
              "value": "positive",
              "mapping_confidence": 0.0,
              "source_text_fragment": "Entity index unknown",
              "mapping_rationale": "HER2 positive status explicitly stated, indicating genomic variant status",
              "id": "0ec728e8-0b7f-4647-88da-a7fdf62a3ef7"
            },
            {
              "resourceType": "Observation",
              "mcode_element": "CancerRelatedMedicationAdministration",
              "code": {
                "system": "http://hl7.org/fhir/us/mCODE",
                "code": "cancerrelatedmedicationadministration",
                "display": "CancerRelatedMedicationAdministration"
              },
              "value": "administered",
              "mapping_confidence": 0.0,
              "source_text_fragment": "Entity index unknown",
              "mapping_rationale": "HER2-targeted therapy mentioned as current treatment regimen",
              "id": "3b0ecdb0-6e0f-40cd-b232-59e9b1b2ffff"
            },
            {
              "resourceType": "Observation",
              "mcode_element": "CancerRelatedSurgicalProcedure",
              "code": {
                "system": "http://hl7.org/fhir/us/mCODE",
                "code": "cancerrelatedsurgicalprocedure",
                "display": "CancerRelatedSurgicalProcedure"
              },
              "value": "planned",
              "mapping_confidence": 0.0,
              "source_text_fragment": "Entity index unknown",
              "mapping_rationale": "Vaccine therapy mentioned as part of the treatment approach",
              "id": "a9d78ef7-7834-4aa2-8d4a-a13581c1bf92"
            },
            {
              "resourceType": "Observation",
              "mcode_element": "CancerRelatedMedicationAdministration",
              "code": {
                "system": "http://hl7.org/fhir/us/mCODE",
                "code": "cancerrelatedmedicationadministration",
                "display": "CancerRelatedMedicationAdministration"
              },
              "value": "under investigation",
              "mapping_confidence": 0.0,
              "source_text_fragment": "Entity index unknown",
              "mapping_rationale": "Polysaccharide-K mentioned as investigational therapy component",
              "id": "8de9214f-6d96-434a-81fe-2f98007cc55f"
            },
            {
              "resourceType": "Observation",
              "mcode_element": "GenomicVariant",
              "code": {
                "system": "http://hl7.org/fhir/us/mCODE",
                "code": "genomicvariant",
                "display": "GenomicVariant"
              },
              "value": "HER2 positive",
              "mapping_confidence": 0.0,
              "source_text_fragment": "Entity index unknown",
              "mapping_rationale": "HER2 status is a key genomic variant inclusion criterion for the study",
              "id": "157d1bb2-2276-47f1-91cb-dbbecf04c5f9"
            },
            {
              "resourceType": "Condition",
              "mcode_element": "CancerCondition",
              "code": {
                "system": "http://hl7.org/fhir/us/mCODE",
                "code": "cancercondition",
                "display": "CancerCondition"
              },
              "value": "stage IV",
              "mapping_confidence": 0.0,
              "source_text_fragment": "Entity index unknown",
              "mapping_rationale": "Study specifically targets patients with stage IV breast cancer",
              "id": "5cd662fd-932d-4407-a474-7d0fbc5de4d1"
            },
            {
              "resourceType": "Observation",
              "mcode_element": "ResearchStudy",
              "code": {
                "system": "http://hl7.org/fhir/us/mCODE",
                "code": "researchstudy",
                "display": "ResearchStudy"
              },
              "value": "HER2 ICD peptide-based vaccine clinical trial",
              "mapping_confidence": 0.0,
              "source_text_fragment": "Entity index unknown",
              "mapping_rationale": "Clinical trial description with treatment arms and interventions",
              "id": "0e28c4fc-56d9-4206-b95e-cdc68dcde705"
            },
            {
              "resourceType": "Observation",
              "mcode_element": "CancerRelatedMedicationStatement",
              "code": {
                "system": "http://hl7.org/fhir/us/mCODE",
                "code": "cancerrelatedmedicationstatement",
                "display": "CancerRelatedMedicationStatement"
              },
              "value": "administered per standard of care",
              "mapping_confidence": 0.0,
              "source_text_fragment": "Entity index unknown",
              "mapping_rationale": "HER2-targeted therapy medication mentioned in treatment protocol",
              "id": "8d19e64e-98e0-4a28-b150-9a963a024cca"
            },
            {
              "resourceType": "Observation",
              "mcode_element": "CancerRelatedMedicationStatement",
              "code": {
                "system": "http://hl7.org/fhir/us/mCODE",
                "code": "cancerrelatedmedicationstatement",
                "display": "CancerRelatedMedicationStatement"
              },
              "value": "administered per standard of care",
              "mapping_confidence": 0.0,
              "source_text_fragment": "Entity index unknown",
              "mapping_rationale": "HER2-targeted therapy medication explicitly listed",
              "id": "2b07f734-a6dd-4cba-87ac-5f241b3ecc62"
            },
            {
              "resourceType": "Observation",
              "mcode_element": "CancerDiseaseStatus",
              "code": {
                "system": "http://hl7.org/fhir/us/mCODE",
                "code": "cancerdiseasestatus",
                "display": "CancerDiseaseStatus"
              },
              "value": "positive",
              "mapping_confidence": 0.0,
              "source_text_fragment": "Entity index unknown",
              "mapping_rationale": "HER2-targeted vaccine implies HER2-positive cancer status",
              "id": "cd90f931-0b7a-4855-a8b2-2d58a235f5f3"
            },
            {
              "resourceType": "Observation",
              "mcode_element": "TumorMarker",
              "code": {
                "system": "http://hl7.org/fhir/us/mCODE",
                "code": "tumormarker",
                "display": "TumorMarker"
              },
              "value": "positive",
              "mapping_confidence": 0.0,
              "source_text_fragment": "Entity index unknown",
              "mapping_rationale": "HER2-targeted therapy indicates HER2 biomarker positivity",
              "id": "c8f92832-fdc8-4a90-bc1a-444fa5e70a19"
            },
            {
              "resourceType": "Observation",
              "mcode_element": "TNMClinicalStageGroup",
              "code": {
                "system": "http://hl7.org/fhir/us/mCODE",
                "code": "tnmclinicalstagegroup",
                "display": "TNMClinicalStageGroup"
              },
              "value": "metastatic or advanced (inferred)",
              "mapping_confidence": 0.0,
              "source_text_fragment": "Entity index unknown",
              "mapping_rationale": "Dual HER2 blockade typically used in metastatic setting",
              "id": "8a7de429-cb1f-452d-b17d-834c085c364e"
            },
            {
              "resourceType": "Observation",
              "mcode_element": "ResearchSubject",
              "code": {
                "system": "http://hl7.org/fhir/us/mCODE",
                "code": "researchsubject",
                "display": "ResearchSubject"
              },
              "value": "clinical trial participant",
              "mapping_confidence": 0.0,
              "source_text_fragment": "Entity index unknown",
              "mapping_rationale": "Clinical trial participants described in treatment arms",
              "id": "2c6954a6-8ffb-4d08-af8d-5d2cd4098c3b"
            },
            {
              "resourceType": "Observation",
              "mcode_element": "CancerRelatedLaboratoryTest",
              "code": {
                "system": "http://hl7.org/fhir/us/mCODE",
                "code": "cancerrelatedlaboratorytest",
                "display": "CancerRelatedLaboratoryTest"
              },
              "value": "correlative studies",
              "mapping_confidence": 0.0,
              "source_text_fragment": "Entity index unknown",
              "mapping_rationale": "Explicit mention of laboratory biomarker analysis",
              "id": "8b64f32f-b238-4d56-a6db-7c15dbda0a39"
            },
            {
              "resourceType": "Observation",
              "mcode_element": "PerformanceStatus",
              "code": {
                "system": "http://hl7.org/fhir/us/mCODE",
                "code": "performancestatus",
                "display": "PerformanceStatus"
              },
              "value": "adequate for clinical trial (inferred)",
              "mapping_confidence": 0.0,
              "source_text_fragment": "Entity index unknown",
              "mapping_rationale": "Clinical trial participation implies adequate performance status",
              "id": "c5659ff7-0cb3-45f8-8c3e-392b76bd7013"
            },
            {
              "resourceType": "Observation",
              "mcode_element": "CancerRelatedSurgicalProcedure",
              "code": {
                "system": "http://hl7.org/fhir/us/mCODE",
                "code": "cancerrelatedsurgicalprocedure",
                "display": "CancerRelatedSurgicalProcedure"
              },
              "value": "intradermal administration",
              "mapping_confidence": 0.0,
              "source_text_fragment": "Entity index unknown",
              "mapping_rationale": "Vaccine administration method specified as intradermal",
              "id": "6602ec6d-5563-4b6e-bcad-ab35472e9d06"
            },
            {
              "resourceType": "Observation",
              "mcode_element": "Toxicity",
              "code": {
                "system": "http://hl7.org/fhir/us/mCODE",
                "code": "toxicity",
                "display": "Toxicity"
              },
              "value": "Grade 3 or higher",
              "mapping_confidence": 0.0,
              "source_text_fragment": "Entity index unknown",
              "mapping_rationale": "Direct mapping to toxicity grading using CTCAE v4.0 terminology",
              "id": "c78061ce-a0e8-40b5-9e17-b3f6e5eee63e"
            },
            {
              "resourceType": "Observation",
              "mcode_element": "Toxicity",
              "code": {
                "system": "http://hl7.org/fhir/us/mCODE",
                "code": "toxicity",
                "display": "Toxicity"
              },
              "value": "Present",
              "mapping_confidence": 0.0,
              "source_text_fragment": "Entity index unknown",
              "mapping_rationale": "Specific toxicity event mentioned in population description",
              "id": "ca3464df-c427-4709-8097-4e8ef7f2f2d4"
            },
            {
              "resourceType": "Observation",
              "mcode_element": "CancerRelatedLaboratoryTest",
              "code": {
                "system": "http://hl7.org/fhir/us/mCODE",
                "code": "cancerrelatedlaboratorytest",
                "display": "CancerRelatedLaboratoryTest"
              },
              "value": "Quantitative",
              "mapping_confidence": 0.0,
              "source_text_fragment": "Entity index unknown",
              "mapping_rationale": "Flow cytometry analysis of NK cell markers CD56 and CD16",
              "id": "9ef04d1b-f026-4751-8415-c806352a9f84"
            },
            {
              "resourceType": "Observation",
              "mcode_element": "CancerRelatedLaboratoryTest",
              "code": {
                "system": "http://hl7.org/fhir/us/mCODE",
                "code": "cancerrelatedlaboratorytest",
                "display": "CancerRelatedLaboratoryTest"
              },
              "value": "Quantitative",
              "mapping_confidence": 0.0,
              "source_text_fragment": "Entity index unknown",
              "mapping_rationale": "Flow cytometry analysis of NK cell markers CD56 and CD16",
              "id": "b585b171-3fe6-489e-89bc-cea448f022f1"
            },
            {
              "resourceType": "Observation",
              "mcode_element": "CancerRelatedLaboratoryTest",
              "code": {
                "system": "http://hl7.org/fhir/us/mCODE",
                "code": "cancerrelatedlaboratorytest",
                "display": "CancerRelatedLaboratoryTest"
              },
              "value": "Quantitative",
              "mapping_confidence": 0.0,
              "source_text_fragment": "Entity index unknown",
              "mapping_rationale": "Direct measurement of IFN-gamma production in NK cells",
              "id": "d486c493-6462-4abe-be4f-4f1127df0329"
            },
            {
              "resourceType": "Observation",
              "mcode_element": "CancerRelatedLaboratoryTest",
              "code": {
                "system": "http://hl7.org/fhir/us/mCODE",
                "code": "cancerrelatedlaboratorytest",
                "display": "CancerRelatedLaboratoryTest"
              },
              "value": "Quantitative",
              "mapping_confidence": 0.0,
              "source_text_fragment": "Entity index unknown",
              "mapping_rationale": "Direct measurement of CD107a expression as marker of NK cell activity",
              "id": "d9a08485-3ce8-45f8-a3ed-b457491414c5"
            },
            {
              "resourceType": "Observation",
              "mcode_element": "CancerRelatedLaboratoryTest",
              "code": {
                "system": "http://hl7.org/fhir/us/mCODE",
                "code": "cancerrelatedlaboratorytest",
                "display": "CancerRelatedLaboratoryTest"
              },
              "value": "Quantitative",
              "mapping_confidence": 0.0,
              "source_text_fragment": "Entity index unknown",
              "mapping_rationale": "ELISPOT assay for IFN-gamma to assess T cell response",
              "id": "1a406d75-7024-44ff-bb4c-e13b45528c85"
            },
            {
              "resourceType": "Observation",
              "mcode_element": "CancerRelatedLaboratoryTest",
              "code": {
                "system": "http://hl7.org/fhir/us/mCODE",
                "code": "cancerrelatedlaboratorytest",
                "display": "CancerRelatedLaboratoryTest"
              },
              "value": "Quantitative",
              "mapping_confidence": 0.0,
              "source_text_fragment": "Entity index unknown",
              "mapping_rationale": "ELISA measurement of TGF-beta levels as cancer biomarker",
              "id": "3f131316-30ec-47cf-bc77-5f73d98a311e"
            },
            {
              "resourceType": "Observation",
              "mcode_element": "CancerDiseaseStatus",
              "code": {
                "system": "http://hl7.org/fhir/us/mCODE",
                "code": "cancerdiseasestatus",
                "display": "CancerDiseaseStatus"
              },
              "value": "Measured",
              "mapping_confidence": 0.0,
              "source_text_fragment": "Entity index unknown",
              "mapping_rationale": "Overall survival as key oncology outcome measure",
              "id": "3144354f-0cfd-4f12-ab68-43e263bdb654"
            },
            {
              "resourceType": "Observation",
              "mcode_element": "CancerDiseaseStatus",
              "code": {
                "system": "http://hl7.org/fhir/us/mCODE",
                "code": "cancerdiseasestatus",
                "display": "CancerDiseaseStatus"
              },
              "value": "Measured",
              "mapping_confidence": 0.0,
              "source_text_fragment": "Entity index unknown",
              "mapping_rationale": "Progression-free survival as key oncology outcome measure",
              "id": "42a4b449-6344-4ead-a493-4436958ac6d2"
            }
          ],
          "source_references": [],
          "validation_results": {
            "valid": true,
            "errors": [],
            "warnings": [],
            "compliance_score": 1.0
          },
          "metadata": {
            "pipeline_version": "Mcode_pipeline_v1",
            "engine_type": "LLM",
            "entities_count": 0,
            "mapped_count": 70,
            "compliance_score": 1.0,
            "token_usage": {
              "prompt_tokens": 2976,
              "completion_tokens": 1321,
              "total_tokens": 4297
            },
            "aggregate_token_usage": {
              "prompt_tokens": 9138,
              "completion_tokens": 9395,
              "total_tokens": 18533,
              "model_name": "deepseek-coder",
              "provider_name": "deepseek"
            }
          }
        },
        {
          "trial_id": "NCT01026116",
          "processing_time": 210.42173194885254,
          "mcode_mappings": [
            {
              "resourceType": "Observation",
              "mcode_element": "ResearchStudy",
              "code": {
                "system": "http://hl7.org/fhir/us/mCODE",
                "code": "researchstudy",
                "display": "ResearchStudy"
              },
              "value": "interventional",
              "mapping_confidence": 0.0,
              "source_text_fragment": "Entity index unknown",
              "mapping_rationale": "TREATMENT purpose indicates an interventional study type per mCODE ResearchStudy profile",
              "id": "55474487-d041-444a-96ed-0c789ca6ee06"
            },
            {
              "resourceType": "Observation",
              "mcode_element": "ResearchStudy",
              "code": {
                "system": "http://hl7.org/fhir/us/mCODE",
                "code": "researchstudy",
                "display": "ResearchStudy"
              },
              "value": "randomized",
              "mapping_confidence": 0.0,
              "source_text_fragment": "Entity index unknown",
              "mapping_rationale": "Direct mapping of RANDOMIZED to FHIR randomized allocation type",
              "id": "6bbba60a-0d1a-473f-801d-e5281cabce98"
            },
            {
              "resourceType": "Observation",
              "mcode_element": "ResearchStudy",
              "code": {
                "system": "http://hl7.org/fhir/us/mCODE",
                "code": "researchstudy",
                "display": "ResearchStudy"
              },
              "value": "parallel",
              "mapping_confidence": 0.0,
              "source_text_fragment": "Entity index unknown",
              "mapping_rationale": "Direct mapping of PARALLEL to FHIR parallel study design",
              "id": "fc727cf7-a74e-465d-9b33-599d4400485c"
            },
            {
              "resourceType": "Observation",
              "mcode_element": "ResearchStudy",
              "code": {
                "system": "http://hl7.org/fhir/us/mCODE",
                "code": "researchstudy",
                "display": "ResearchStudy"
              },
              "value": "none",
              "mapping_confidence": 0.0,
              "source_text_fragment": "Entity index unknown",
              "mapping_rationale": "Direct mapping of NONE to FHIR no masking type",
              "id": "72446141-1ae1-41ca-a2e8-3b902867195d"
            },
            {
              "resourceType": "Condition",
              "mcode_element": "CancerCondition",
              "code": {
                "system": "http://hl7.org/fhir/us/mCODE",
                "code": "cancercondition",
                "display": "CancerCondition"
              },
              "value": "active",
              "mapping_confidence": 0.0,
              "source_text_fragment": "Entity index unknown",
              "mapping_rationale": "The term 'Breast Neoplasms' maps to SNOMED CT code 254837009 for malignant neoplasm of breast, which is a primary cancer condition in mCODE",
              "id": "43b379f8-41d4-47cd-a5c6-de5595b7395b"
            },
            {
              "resourceType": "Condition",
              "mcode_element": "CancerCondition",
              "code": {
                "system": "http://hl7.org/fhir/us/mCODE",
                "code": "cancercondition",
                "display": "CancerCondition"
              },
              "value": "present",
              "mapping_confidence": 0.0,
              "source_text_fragment": "Entity index unknown",
              "mapping_rationale": "Text confirms breast cancer diagnosis with histological verification",
              "id": "c7b49e66-99bb-449a-91b9-711792680ecc"
            },
            {
              "resourceType": "Condition",
              "mcode_element": "CancerCondition",
              "code": {
                "system": "http://hl7.org/fhir/us/mCODE",
                "code": "cancercondition",
                "display": "CancerCondition"
              },
              "value": "present",
              "mapping_confidence": 0.0,
              "source_text_fragment": "Entity index unknown",
              "mapping_rationale": "Cancer stage range includes stage I, mapped to SNOMED CT code for stage I breast cancer",
              "id": "79b050b7-feef-4b56-b71d-e331552a225c"
            },
            {
              "resourceType": "Condition",
              "mcode_element": "CancerCondition",
              "code": {
                "system": "http://hl7.org/fhir/us/mCODE",
                "code": "cancercondition",
                "display": "CancerCondition"
              },
              "value": "present",
              "mapping_confidence": 0.0,
              "source_text_fragment": "Entity index unknown",
              "mapping_rationale": "Cancer stage range includes stage II, mapped to SNOMED CT code for stage II breast cancer",
              "id": "78acda31-eca9-4730-839b-938faa57db67"
            },
            {
              "resourceType": "Condition",
              "mcode_element": "CancerCondition",
              "code": {
                "system": "http://hl7.org/fhir/us/mCODE",
                "code": "cancercondition",
                "display": "CancerCondition"
              },
              "value": "present",
              "mapping_confidence": 0.0,
              "source_text_fragment": "Entity index unknown",
              "mapping_rationale": "Cancer stage range includes stage III, mapped to SNOMED CT code for stage III breast cancer",
              "id": "f0e3aa9d-4491-45b3-adb3-44b55acc4ea3"
            },
            {
              "resourceType": "Observation",
              "mcode_element": "CancerRelatedSurgicalProcedure",
              "code": {
                "system": "http://hl7.org/fhir/us/mCODE",
                "code": "cancerrelatedsurgicalprocedure",
                "display": "CancerRelatedSurgicalProcedure"
              },
              "value": "performed",
              "mapping_confidence": 0.0,
              "source_text_fragment": "Entity index unknown",
              "mapping_rationale": "Describes surgical procedure for breast cancer treatment including margin clearance and axillary dissection",
              "id": "4c2d9955-fa1b-499e-beac-fe7d274fee46"
            },
            {
              "resourceType": "Observation",
              "mcode_element": "ERStatus",
              "code": {
                "system": "http://hl7.org/fhir/us/mCODE",
                "code": "erstatus",
                "display": "ERStatus"
              },
              "value": "positive",
              "mapping_confidence": 0.0,
              "source_text_fragment": "Entity index unknown",
              "mapping_rationale": "Explicitly states ER positive status with specific immunohistochemical criteria",
              "id": "8764ff5e-4afb-47a5-a1a4-95001b1352da"
            },
            {
              "resourceType": "Observation",
              "mcode_element": "HER2Status",
              "code": {
                "system": "http://hl7.org/fhir/us/mCODE",
                "code": "her2status",
                "display": "HER2Status"
              },
              "value": "negative",
              "mapping_confidence": 0.0,
              "source_text_fragment": "Entity index unknown",
              "mapping_rationale": "Explicitly states HER2 negative status with specific test criteria",
              "id": "6d2c0142-8e1e-48f6-8ee8-54e01f4214f4"
            },
            {
              "resourceType": "Observation",
              "mcode_element": "RegionalNodesPositive",
              "code": {
                "system": "http://hl7.org/fhir/us/mCODE",
                "code": "regionalnodespositive",
                "display": "RegionalNodesPositive"
              },
              "value": "present",
              "mapping_confidence": 0.0,
              "source_text_fragment": "Entity index unknown",
              "mapping_rationale": "Confirms presence of positive regional lymph nodes in breast cancer",
              "id": "51b95603-a3de-43d8-8ecd-593346375caf"
            },
            {
              "resourceType": "Observation",
              "mcode_element": "ECOGPerformanceStatus",
              "code": {
                "system": "http://hl7.org/fhir/us/mCODE",
                "code": "ecogperformancestatus",
                "display": "ECOGPerformanceStatus"
              },
              "value": "0-1",
              "mapping_confidence": 0.0,
              "source_text_fragment": "Entity index unknown",
              "mapping_rationale": "Direct mapping of ECOG performance status score range",
              "id": "a5e38fc9-502b-4851-a167-c5cbe237e1ab"
            },
            {
              "resourceType": "Observation",
              "mcode_element": "Patient",
              "code": {
                "system": "http://hl7.org/fhir/us/mCODE",
                "code": "patient",
                "display": "Patient"
              },
              "value": "female",
              "mapping_confidence": 0.0,
              "source_text_fragment": "Entity index unknown",
              "mapping_rationale": "Explicit gender specification for patient population",
              "id": "2a41be5a-38ca-4a2f-8f32-49cf9e07035e"
            },
            {
              "resourceType": "Observation",
              "mcode_element": "Patient",
              "code": {
                "system": "http://hl7.org/fhir/us/mCODE",
                "code": "patient",
                "display": "Patient"
              },
              "value": "18-40",
              "mapping_confidence": 0.0,
              "source_text_fragment": "Entity index unknown",
              "mapping_rationale": "Age range specification for patient eligibility",
              "id": "bdf1f18e-7014-4fa2-b8bd-9c08ff7d9268"
            },
            {
              "resourceType": "Observation",
              "mcode_element": "Comorbidity",
              "code": {
                "system": "http://hl7.org/fhir/us/mCODE",
                "code": "comorbidity",
                "display": "Comorbidity"
              },
              "value": "present",
              "mapping_confidence": 0.0,
              "source_text_fragment": "Entity index unknown",
              "mapping_rationale": "Indicates absence of significant cardiac comorbidity through adequate function assessment",
              "id": "8f393f3d-b0ed-4a8e-81df-b6134ad54981"
            },
            {
              "resourceType": "Observation",
              "mcode_element": "Comorbidity",
              "code": {
                "system": "http://hl7.org/fhir/us/mCODE",
                "code": "comorbidity",
                "display": "Comorbidity"
              },
              "value": "present",
              "mapping_confidence": 0.0,
              "source_text_fragment": "Entity index unknown",
              "mapping_rationale": "Indicates absence of significant renal comorbidity through adequate function assessment",
              "id": "b3944b3a-9786-478f-8995-384d64c48e77"
            },
            {
              "resourceType": "Observation",
              "mcode_element": "Comorbidity",
              "code": {
                "system": "http://hl7.org/fhir/us/mCODE",
                "code": "comorbidity",
                "display": "Comorbidity"
              },
              "value": "present",
              "mapping_confidence": 0.0,
              "source_text_fragment": "Entity index unknown",
              "mapping_rationale": "Indicates absence of significant hepatic comorbidity through adequate function assessment",
              "id": "8b798fe7-00a4-422c-8939-96f9b5019bd7"
            },
            {
              "resourceType": "Observation",
              "mcode_element": "CancerDiseaseStatus",
              "code": {
                "system": "http://hl7.org/fhir/us/mCODE",
                "code": "cancerdiseasestatus",
                "display": "CancerDiseaseStatus"
              },
              "value": "absent",
              "mapping_confidence": 0.0,
              "source_text_fragment": "Entity index unknown",
              "mapping_rationale": "Exclusion of metastatic disease implies absence of metastasis for included patients",
              "id": "86fad1b3-0e6d-49e9-b384-840d4bb3783b"
            },
            {
              "resourceType": "Condition",
              "mcode_element": "CancerCondition",
              "code": {
                "system": "http://hl7.org/fhir/us/mCODE",
                "code": "cancercondition",
                "display": "CancerCondition"
              },
              "value": "present",
              "mapping_confidence": 0.0,
              "source_text_fragment": "Entity index unknown",
              "mapping_rationale": "Text explicitly mentions breast cancer patients, indicating presence of cancer condition",
              "id": "6cc5061a-c8bd-4d0d-aa8c-baf81ccce2fe"
            },
            {
              "resourceType": "Observation",
              "mcode_element": "CancerDiseaseStatus",
              "code": {
                "system": "http://hl7.org/fhir/us/mCODE",
                "code": "cancerdiseasestatus",
                "display": "CancerDiseaseStatus"
              },
              "value": "active",
              "mapping_confidence": 0.0,
              "source_text_fragment": "Entity index unknown",
              "mapping_rationale": "Reference to patients implies active disease status requiring treatment",
              "id": "a18e02b7-7f90-431a-af75-4a4581056d93"
            },
            {
              "resourceType": "Observation",
              "mcode_element": "CancerRelatedMedicationStatement",
              "code": {
                "system": "http://hl7.org/fhir/us/mCODE",
                "code": "cancerrelatedmedicationstatement",
                "display": "CancerRelatedMedicationStatement"
              },
              "value": "planned",
              "mapping_confidence": 0.0,
              "source_text_fragment": "Entity index unknown",
              "mapping_rationale": "Paclitaxel is explicitly mentioned as part of the treatment strategy being evaluated",
              "id": "bd71553d-da08-4942-b570-b9ceaaed580c"
            },
            {
              "resourceType": "Observation",
              "mcode_element": "CancerRelatedMedicationStatement",
              "code": {
                "system": "http://hl7.org/fhir/us/mCODE",
                "code": "cancerrelatedmedicationstatement",
                "display": "CancerRelatedMedicationStatement"
              },
              "value": "planned",
              "mapping_confidence": 0.0,
              "source_text_fragment": "Entity index unknown",
              "mapping_rationale": "Anthracycline-based regimens are mentioned as the foundation for treatment strategies",
              "id": "b189924b-3f0a-47b0-b37c-ce4cf7a5c21c"
            },
            {
              "resourceType": "Observation",
              "mcode_element": "TumorMarker",
              "code": {
                "system": "http://hl7.org/fhir/us/mCODE",
                "code": "tumormarker",
                "display": "TumorMarker"
              },
              "value": "aggressive",
              "mapping_confidence": 0.0,
              "source_text_fragment": "Entity index unknown",
              "mapping_rationale": "Text describes patients as having aggressive clinical history, which is a tumor marker characteristic",
              "id": "869e4b21-db1d-48f3-a55b-7c69aa0cc140"
            },
            {
              "resourceType": "Observation",
              "mcode_element": "Patient",
              "code": {
                "system": "http://hl7.org/fhir/us/mCODE",
                "code": "patient",
                "display": "Patient"
              },
              "value": "young",
              "mapping_confidence": 0.0,
              "source_text_fragment": "Entity index unknown",
              "mapping_rationale": "Text specifies 'young' patients, indicating age is a relevant demographic factor",
              "id": "ab54d24b-2d6f-452d-8553-84725688b145"
            },
            {
              "resourceType": "Observation",
              "mcode_element": "ResearchStudy",
              "code": {
                "system": "http://hl7.org/fhir/us/mCODE",
                "code": "researchstudy",
                "display": "ResearchStudy"
              },
              "value": "true",
              "mapping_confidence": 0.0,
              "source_text_fragment": "Entity index unknown",
              "mapping_rationale": "Text explicitly describes a research study purpose and objectives",
              "id": "98d59112-db85-446e-832b-a373c77076aa"
            },
            {
              "resourceType": "Condition",
              "mcode_element": "CancerCondition",
              "code": {
                "system": "http://hl7.org/fhir/us/mCODE",
                "code": "cancercondition",
                "display": "CancerCondition"
              },
              "value": "present",
              "mapping_confidence": 0.0,
              "source_text_fragment": "Entity index unknown",
              "mapping_rationale": "Text explicitly mentions 'Breast Cancer' which maps to SNOMED CT code for malignant neoplasm of breast",
              "id": "95db2084-af7b-4562-abed-db5dfa675c83"
            },
            {
              "resourceType": "Observation",
              "mcode_element": "CancerDiseaseStatus",
              "code": {
                "system": "http://hl7.org/fhir/us/mCODE",
                "code": "cancerdiseasestatus",
                "display": "CancerDiseaseStatus"
              },
              "value": "post-operative",
              "mapping_confidence": 0.0,
              "source_text_fragment": "Entity index unknown",
              "mapping_rationale": "'Operable' implies the cancer is in a state where surgery is possible, indicating post-operative status for adjuvant therapy",
              "id": "095432b3-e60c-4a52-8e53-df41ce513227"
            },
            {
              "resourceType": "Observation",
              "mcode_element": "CancerRelatedMedicationStatement",
              "code": {
                "system": "http://hl7.org/fhir/us/mCODE",
                "code": "cancerrelatedmedicationstatement",
                "display": "CancerRelatedMedicationStatement"
              },
              "value": "administered",
              "mapping_confidence": 0.0,
              "source_text_fragment": "Entity index unknown",
              "mapping_rationale": "'EC' in chemotherapy regimen typically refers to Epirubicin + Cyclophosphamide",
              "id": "45199cb4-91f3-4714-8051-ef7f4edb5759"
            },
            {
              "resourceType": "Observation",
              "mcode_element": "CancerRelatedMedicationStatement",
              "code": {
                "system": "http://hl7.org/fhir/us/mCODE",
                "code": "cancerrelatedmedicationstatement",
                "display": "CancerRelatedMedicationStatement"
              },
              "value": "administered",
              "mapping_confidence": 0.0,
              "source_text_fragment": "Entity index unknown",
              "mapping_rationale": "'EC' in chemotherapy regimen typically refers to Epirubicin + Cyclophosphamide",
              "id": "4429e985-ed39-4aa7-8316-c96978a2768e"
            },
            {
              "resourceType": "Observation",
              "mcode_element": "CancerRelatedMedicationStatement",
              "code": {
                "system": "http://hl7.org/fhir/us/mCODE",
                "code": "cancerrelatedmedicationstatement",
                "display": "CancerRelatedMedicationStatement"
              },
              "value": "administered",
              "mapping_confidence": 0.0,
              "source_text_fragment": "Entity index unknown",
              "mapping_rationale": "'wP' likely refers to weekly Paclitaxel regimen in adjuvant chemotherapy",
              "id": "a189d116-b2da-4c9a-b95a-a8a92f57c79c"
            },
            {
              "resourceType": "Observation",
              "mcode_element": "CancerRelatedMedicationStatement",
              "code": {
                "system": "http://hl7.org/fhir/us/mCODE",
                "code": "cancerrelatedmedicationstatement",
                "display": "CancerRelatedMedicationStatement"
              },
              "value": "administered",
              "mapping_confidence": 0.0,
              "source_text_fragment": "Entity index unknown",
              "mapping_rationale": "'EP' could refer to Epirubicin + Platinum agent (likely Cisplatin) in chemotherapy regimen",
              "id": "8532b2d9-5926-4177-a867-d78363f366c7"
            },
            {
              "resourceType": "Observation",
              "mcode_element": "CancerRelatedSurgicalProcedure",
              "code": {
                "system": "http://hl7.org/fhir/us/mCODE",
                "code": "cancerrelatedsurgicalprocedure",
                "display": "CancerRelatedSurgicalProcedure"
              },
              "value": "performed",
              "mapping_confidence": 0.0,
              "source_text_fragment": "Entity index unknown",
              "mapping_rationale": "'Operable' implies surgical intervention is planned or has occurred for breast cancer treatment",
              "id": "0fe890a0-9f28-4d78-b678-b7a8a94b2d57"
            },
            {
              "resourceType": "Observation",
              "mcode_element": "TNMClinicalStageGroup",
              "code": {
                "system": "http://hl7.org/fhir/us/mCODE",
                "code": "tnmclinicalstagegroup",
                "display": "TNMClinicalStageGroup"
              },
              "value": "unknown",
              "mapping_confidence": 0.0,
              "source_text_fragment": "Entity index unknown",
              "mapping_rationale": "'Operable' suggests early stage cancer but specific TNM stage is not provided in text",
              "id": "ab65661d-be3d-4e36-81ec-bf2a801eec39"
            },
            {
              "resourceType": "Observation",
              "mcode_element": "GenomicVariant",
              "code": {
                "system": "http://hl7.org/fhir/us/mCODE",
                "code": "genomicvariant",
                "display": "GenomicVariant"
              },
              "value": "not assessed",
              "mapping_confidence": 0.0,
              "source_text_fragment": "Entity index unknown",
              "mapping_rationale": "Clinical trial context suggests genomic variants may be assessed but no specific variants mentioned in provided text",
              "id": "0e085afa-ffeb-4d73-b527-8e68a351d170"
            },
            {
              "resourceType": "Observation",
              "mcode_element": "Patient",
              "code": {
                "system": "http://hl7.org/fhir/us/mCODE",
                "code": "patient",
                "display": "Patient"
              },
              "value": "age < 40 years",
              "mapping_confidence": 0.0,
              "source_text_fragment": "Entity index unknown",
              "mapping_rationale": "Text specifies patient population as breast cancer patients under 40 years old",
              "id": "076b6997-7a3a-469c-96fb-4cc6808a6cc8"
            }
          ],
          "source_references": [],
          "validation_results": {
            "valid": true,
            "errors": [],
            "warnings": [],
            "compliance_score": 1.0
          },
          "metadata": {
            "pipeline_version": "Mcode_pipeline_v1",
            "engine_type": "LLM",
            "entities_count": 0,
            "mapped_count": 37,
            "compliance_score": 1.0,
            "token_usage": {
              "prompt_tokens": 558,
              "completion_tokens": 1312,
              "total_tokens": 1870
            },
            "aggregate_token_usage": {
              "prompt_tokens": 2991,
              "completion_tokens": 4830,
              "total_tokens": 7821,
              "model_name": "deepseek-coder",
              "provider_name": "deepseek"
            }
          }
        }
      ],
      "quality_analysis": {
        "total_mappings": 107,
        "avg_confidence": 0.0,
        "high_confidence_count": 0,
        "with_source_text": 0,
        "source_text_ratio": 0.0,
        "confidence_distribution": {
          "high (0.8-1.0)": 0,
          "medium (0.5-0.8)": 0,
          "low (0.0-0.5)": 107
        },
        "quality_score": 0.0
      }
    },
    "direct_mcode_evidence_based_concise": {
      "prompt_name": "direct_mcode_evidence_based_concise",
      "model_name": "deepseek-coder",
      "trials_processed": 2,
      "total_processing_time": 0,
      "trial_results": [
        {
          "error": "Failed to initialize McodeMapper: Failed to initialize McodeMapper: RESPONSE STRUCTURE VALIDATION FAILED for 'direct_mcode_evidence_based_concise'. Prompt type 'DIRECT_MCODE' requires: Direct mCODE mapping prompts must produce JSON with 'mcode_mappings' array field. Validation errors: [\"Missing required field: 'mcode_mappings'\"]. This prompt will be skipped to prevent runtime errors.",
          "trial_id": "NCT01922921",
          "processing_time": 0,
          "mcode_mappings": []
        },
        {
          "error": "Failed to initialize McodeMapper: Failed to initialize McodeMapper: RESPONSE STRUCTURE VALIDATION FAILED for 'direct_mcode_evidence_based_concise'. Prompt type 'DIRECT_MCODE' requires: Direct mCODE mapping prompts must produce JSON with 'mcode_mappings' array field. Validation errors: [\"Missing required field: 'mcode_mappings'\"]. This prompt will be skipped to prevent runtime errors.",
          "trial_id": "NCT01026116",
          "processing_time": 0,
          "mcode_mappings": []
        }
      ],
      "quality_analysis": {
        "total_mappings": 0,
        "avg_confidence": 0.0,
        "high_confidence_count": 0,
        "with_source_text": 0,
        "source_text_ratio": 0.0,
        "confidence_distribution": {},
        "quality_score": 0.0
      }
    }
  },
  "validation_analysis": {
    "improvements_detected": [
      "Reduced over-mapping: 0 vs 107 mappings (quality over quantity)"
    ],
    "concerns_identified": [],
    "overall_assessment": "moderate_improvement"
  },
  "recommendations": [
    "\u2705 Evidence-based prompt shows promise",
    "\ud83d\udd27 Consider additional refinements based on specific improvements",
    "\ud83e\uddea Run larger-scale validation before production deployment",
    "\ud83d\udd27 Improve source text fragment capture mechanism",
    "\ud83d\udd27 Refine confidence scoring calibration"
  ]
}